Literature DB >> 8248131

A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions.

M F Callan1, H T Reyburn, P Bowness, T H Ottenhoff, I Engel, R D Klausner, J I Bell, A McMichael.   

Abstract

Study of the T-cell repertoire in humans has been hampered by the lack of monoclonal antibodies (mAbs) to the T-cell receptor (TCR) variable region (V) gene products. We describe a method for producing mAbs to the human TCR beta-chain V (V beta) gene products in which mice were immunized with a rat basophil cell line (RBL-2H3) transfected with the extracellular domain of the TCR heterodimer fused to the lambda chain of CD3. These cells acted as excellent immunogens for raising anti-TCR mAb and also formed the basis of a rapid screening assay. We generated mAbs against V beta protein of the TCR, showed that these mAbs stained approximately 1% of peripheral blood T cells, and further showed that the mAbs could stimulate proliferation of these T cells. We then characterized the mAbs by amplifying TCR cDNA derived from mAb-stimulated cells and sequencing the beta chain. All clones sequenced used the V beta 7.1 chain, proving conclusively that the mAbs generated were specific for V beta 7.1 subfamily. This method generates mAbs to human TCR V beta proteins efficiently and might allow production of a complete panel of mAbs directed against human TCR V beta proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248131      PMCID: PMC47795          DOI: 10.1073/pnas.90.22.10454

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Inherited polymorphism of the human T-cell antigen receptor detected by a monoclonal antibody.

Authors:  D N Posnett; C Y Wang; S M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Preparation of monoclonal antibodies: strategies and procedures.

Authors:  G Galfrè; C Milstein
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Fine specificity of monoclonal antibodies directed at human T cell receptor variable regions: comparison with oligonucleotide-driven amplification for evaluation of V beta expression.

Authors:  A Diu; F Romagné; C Genevée; C Rocher; J M Bruneau; A David; F Praz; T Hercend
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

4.  Growth of normal human T lymphocytes induced by monoclonal antibody to the T cell antigen receptor.

Authors:  A W Boylston; P Cosford
Journal:  Eur J Immunol       Date:  1985-07       Impact factor: 5.532

5.  Characterization and expression of the human alpha beta T cell receptor by using a framework monoclonal antibody.

Authors:  M B Brenner; J McLean; H Scheft; R A Warnke; N Jones; J L Strominger
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

6.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.

Authors:  J L Urban; V Kumar; D H Kono; C Gomez; S J Horvath; J Clayton; D G Ando; E E Sercarz; L Hood
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

7.  Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor.

Authors:  R D Bigler; D N Posnett; N Chiorazzi
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

8.  Oligoclonal expansion of major histocompatibility complex class I-restricted cytolytic T lymphocytes during a primary immune response in vivo: direct monitoring by flow cytometry and polymerase chain reaction.

Authors:  H R MacDonald; J L Casanova; J L Maryanski; J C Cerottini
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

9.  Molecular analysis of T cell receptor (Ti) variable region (V) gene expression. Evidence that a single Ti beta V gene family can be used in formation of V domains on phenotypically and functionally diverse T cell populations.

Authors:  O Acuto; T J Campen; H D Royer; R E Hussey; C B Poole; E L Reinherz
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

10.  Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients.

Authors:  H DerSimonian; M Sugita; D N Glass; A L Maier; M E Weinblatt; T Rème; M B Brenner
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  4 in total

1.  Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.

Authors:  G Zhong; C Reis e Sousa; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

2.  A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.

Authors:  F M Batliwalla; B A Bateman; D Serrano; D Murray; S Macphail; V C Maino; J C Ansel; P K Gregersen; C A Armstrong
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

3.  Oligoclonal activation of CD4+ T lymphocytes in posterior uveitis.

Authors:  E J Feron; V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

4.  T cell receptor sequencing in autoimmunity.

Authors:  Angela M Mitchell; Aaron W Michels
Journal:  J Life Sci (Westlake Village)       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.